Seto, Takashi
https://orcid.org/0000-0002-2960-4364
Mayo Clinic
Precision Medicine Asia (PREMIA) Co. Ltd, Tokyo, Japan
Citations 1
TRUST-II: a global phase II study of taletrectinib in ROS1 -positive non-small-cell lung cancer and other solid tumors
Nagasaka, Misako , Ohe, Yuichiro , Zhou, Caicun , Yang, Nong , Liu, Geoffrey , Felip, Enriqueta , Pérol, M. , Besse, Benjamin , Nieva, Jorgé , Marinis, Filippo de , Seto, Takashi , Hu, Zheyi, Pan, Max Yu-Chen , Li, Shuanglian, Nagasaka, Misako , Yang, Nong , Felip, Enriqueta , Besse, Benjamin , Nieva, Jorge , Raez, Luis , Pennell, Nathan A , Dimou, Anastasios , Seto, Takashi , Ou, Sai-Hong I , Liu, Geoffrey , Choi, Chang‐Min , Dimou, Anastasios , Ciardiello, Fortunato , Pan, Max, Wang, Weiqing , Ou, Sai‐Hong Ignatius
Future Oncology | May 17, 2024 | Volume: 19 | Issue: 2 | Pages: 123-135
